MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Rigel Pharmaceuticals Total Inventories 2011-2025 | RIGL
Annual Total Inventories Rigel Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 M | 5.52 M | 9.12 M | 6.62 M | 1.64 M | 1.35 M | 894 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.12 M | 894 K | 4.45 M |
Quarterly Total Inventories Rigel Pharmaceuticals
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.3 M | 10.4 M | 4.66 M | 4.78 M | 8.06 M | 6.58 M | 6.11 M | 10.8 M | 11.1 M | 9.12 M | 7.12 M | - | 6.76 M | 6.62 M | 7.04 M | 6.83 M | 6.95 M | 1.64 M | 1.64 M | 1.64 M | 1.64 M | 1.35 M | 1.35 M | 1.35 M | 1.35 M | 894 K | 894 K | 894 K | 894 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.3 M | 894 K | 5.06 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aclaris Therapeutics
ACRS
|
791 K | $ 3.2 | -1.69 % | $ 247 M |  USA |
 |
Aptevo Therapeutics
APVO
|
1.78 M | $ 1.07 | -5.75 % | $ 295 K | USA |
 |
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
154 M | $ 26.45 | 4.67 % | $ 1.28 B | USA |
 |
Anika Therapeutics
ANIK
|
46.4 M | $ 9.6 | 0.37 % | $ 141 M | USA |
 |
Catalyst Biosciences
CBIO
|
4.28 M | $ 12.98 | -7.91 % | $ 854 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
6.71 M | - | -6.81 % | $ 3.04 B | USA |
 |
Axon Enterprise
AXON
|
265 M | $ 548.58 | -2.78 % | $ 41.6 B | USA |
 |
Aytu BioScience
AYTU
|
11.4 M | $ 2.37 | 2.83 % | $ 14.9 M | USA |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | USA |
 |
BeiGene, Ltd.
BGNE
|
495 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
80.6 M | $ 11.33 | -1.78 % | $ 733 M | USA |
 |
Biogen
BIIB
|
2.46 B | $ 175.2 | 0.63 % | $ 25.5 B | USA |
 |
Abeona Therapeutics
ABEO
|
194 K | $ 5.07 | -5.5 % | $ 108 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
12.4 M | $ 87.67 | -0.36 % | $ 9.05 B | USA |
 |
ADiTx Therapeutics
ADTX
|
11.2 K | $ 1.43 | -36.18 % | $ 18.8 K | USA |
 |
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
19.5 M | $ 24.29 | 2.84 % | $ 2.88 B | USA |